Cyclopharm (CYC) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock CYC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Cyclopharm Achieves Record Revenue and Expands U.S. Market PresenceAugust 27, 2025 | tipranks.comCyclopharm Limited to Host Webinar on 1H 2025 Results and Future ProspectsAugust 27, 2025 | tipranks.comCyclopharm Limited Secures Shareholder Approval for Key Resolutions at AGMMay 29, 2025 | tipranks.comCyclopharm Limited Expands US Market Presence with Technegas™May 29, 2025 | tipranks.comCyclopharm Achieves Record Sales with US Expansion in 2024May 29, 2025 | tipranks.comCyclopharm Limited Releases Cautious Financial ProjectionsMay 29, 2025 | tipranks.comCyclopharm Limited Announces 2025 Annual General MeetingApril 29, 2025 | tipranks.comCyclopharm to Present at NWR Virtual Healthcare ConferenceMarch 18, 2025 | tipranks.comCyclopharm to Provide Key Business Update on March 19, 2025March 16, 2025 | tipranks.comCyclopharm Secures 5-Year Agreement with US Veterans AdministrationMarch 13, 2025 | tipranks.comCyclopharm Limited Announces AGM Date and Director Nomination DeadlineMarch 10, 2025 | tipranks.comCyclopharm Director Increases Shareholding, Signaling ConfidenceFebruary 25, 2025 | tipranks.comCyclopharm Director Increases ShareholdingFebruary 25, 2025 | tipranks.comCyclopharm Substantial Shareholder Interest UpdateJanuary 27, 2025 | tipranks.comCyclopharm Responds to ASX Inquiry on Share Trading SurgeJanuary 5, 2025 | tipranks.comWe're Interested To See How Cyclopharm (ASX:CYC) Uses Its Cash Hoard To GrowJanuary 11, 2023 | finance.yahoo.comFurther weakness as Cyclopharm (ASX:CYC) drops 13% this week, taking one-year losses to 59%January 11, 2023 | finance.yahoo.comCyclopharm's (ASX:CYC) investors will be pleased with their favorable 42% return over the last five yearsJanuary 11, 2023 | finance.yahoo.com Get Cyclopharm News Delivered to You Automatically Sign up to receive the latest news and ratings for CYC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CYC Media Mentions By Week CYC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYC News Sentiment▼0.000.70▲Average Medical News Sentiment CYC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYC Articles This Week▼00▲CYC Articles Average Week Get the Latest News and Ratings for CYC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Cyclopharm and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies HTL News Today NIOX News Today SBS News Today PRN News Today QIPT News Today EKF News Today CREO News Today TLT News Today NCYT News Today IHC News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:CYC) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclopharm Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclopharm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYC Stock Alerts